期刊文献+

CBLB502蛋白原核表达及辐射防护作用验证 被引量:2

Expression of CBLB502 in prokaryocytes and verification of radiation protective effect
原文传递
导出
摘要 目的原核表达并纯化TLR5受体的激动剂CBLB502蛋白,验证其辐射防护作用。方法采用pET28b原核表达系统表达CBLB502蛋白,利用Ni-NTA亲和层析柱亲和层析纯化CBLB502蛋白,经报告基因检测方法结合动物实验评价纯化蛋白活性。结果成功表达并纯化CBLB502蛋白,纯度可达95%以上,能够激活NF—κB报告基因,可以提高9Gy照射小鼠存活率,对照组小鼠全部死亡,CBLB502蛋白预防组全部存活。结论成功表达并纯化CBLB502蛋白,并验证其对小鼠的辐射防护作用。 Objective To obtain the purified CBLBS02 protein as an agonist of Toll like receptor 5 in prokaryocytes and to validate its radiation protective effect. Methods pET28b expression system was used to express CBLBS02 protein, and the Ni-NTA agarose and purification column was used to purify CBLB502 protein. The radiation proective effect of CBLB502 was evaluated by NF-κB reporter gene assay and mice experiments. Results CBLB502 protein was expressed and purified, which could activate NF- κB reporter gene in vitro and improved the livability of irradiated mice by 9 Gy T-ray. Conclusions CBLB502 protein could be successfully expressed and purified using prokaryotic expression system. It has the excellent radiation protective effect in mice.
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2010年第2期169-172,共4页 Chinese Journal of Radiological Medicine and Protection
关键词 TLR5 CBLB502蛋白 辐射防护 Toll-like receptor 5 CBLB502 protein Radiation protection
  • 相关文献

参考文献8

  • 1Kawai T,Akira S.TLR signaling.Cell Death Differ,2006,13(5):816-825.
  • 2Burdelya LG,Krivokrysenko VI,Tallant TC,ct al.An agonist of toll-like receptor 5 has mdioprotective activity in mouse and primate models.Science,2008,320(5873):226-230.
  • 3Vijay-Kumar M,Aitken JD,Sanders CJ,et al.Flagellin treatment protects against chemicals,bacteria,viruses,and radiation.J Immnnol.2008,180(12):8280-8285.
  • 4Eaves-Pyles T,Murthy K,Liaudet L,ct al.Flagellin,a novel mediator of Salmonella-induced epithelial activation and svstemic inflammation:I kappa B alpha dearadation,induction of nitric oxide synthase,induction of proinflammatory mediators,and cardiovascular dysfunction.J Immunol,2001,166(2):1248-1260.
  • 5Wang Y,Meng A,Lang H,et al.Activation of nuclear factor KB in vivo selectively protects the murine small intestine againat ionizing radiation-induced damage.Cancer Res,2004,64(17):6240-6246.
  • 6Maaser C,Heidamann J,von Eiff C.ct al.Human intestinal microvascular endothelial cells express toll-like receptor 5:a binding partner for bacterial flagellin.J Immunol,2004,172(8):5056-5062.
  • 7Paris F,Fuks z,Kang A,et al.Endothelial apoptosis.as the primary lesion initiating intestinal radiation damage in mice.Science,2001,293(5528):293-297.
  • 8Pasare C,Medzhitov R.Toll-like receptors:linking innate and adaptive immunity.Microbes Infect,2004,6(15):1382-1387.

同被引文献31

  • 1王坚镪,汤瑾,蒋燕群.益生菌对大鼠肠道菌群紊乱和细菌易位的影响[J].上海交通大学学报(医学版),2006,26(2):163-165. 被引量:15
  • 2陈春华,邱立华.消化道肿瘤化疗相关性腹泻的菌群分布及治疗研究[J].临床消化病杂志,2006,18(2):89-90. 被引量:9
  • 3Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity[J]. Nat Immunol, 2001,2(S):675-680.
  • 4Paul C, Faqi A S. Developmental toxicity study of CBLB502 in Wistar rats[J]. Reprod Toxicol, 2014,46(7):12-19.
  • 5Yoon S I, Kurnasov O, Natarajan V, et al. Structural basis of TLR5-flagellin recognition and signaling[J]. Science, 2012,335 (6070):859-864.
  • 6Burdelya L G, Krivokrysenko V I, Tallant T C, et al. An agonist of toll-like receptor 5 has radioproteetive activity in mouse and primate models[J]. Science, 2008,320(5873):226230.
  • 7Kojouharov B M, Brackett C M, Veith J M, et al. Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouraeil by reducing its toxicity to normal tissues in mice[J]. Oneotarget, 2014,5(3):802.
  • 8Burdelya L G, Brackett C M, Kojouharov B, et al. Central role of liver in antieaneer and radioprotective activities of Toll-like receptor 5 agonist[J]. Proc Natl Acad Sei USA, 2013,110(20):E 1857 -E 1866.
  • 9Burdelya L G, Gleiberman A S, Toshkov I, et al. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation:implications for head-and-neck cancer radiotherapy[J]. Int J Radiation Oncol Biol Phys, 2012, 83(1):228-234.
  • 10Fukuzawa N, Petro M, Baldwin W M, et al. A TLR5 agonist inhibits acute renal ischemic failure[J]. J Immunol, 2011,187 (7):3831-3839.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部